The strong negative amide III (at 1247, 1270/1278 band ratio and 1438 cm−1) Raman bands suggest a decreased HER2 amplification when control (HER2− control and HER2+ control) cell spectra were subtracted from that of BT474 cancer cells. The gene discussed is ERBB2; the disease is cancer.